mProbe Taiwan Inc.
Update：2026/11/10
Industries
Main Industry
Health Care
Main Product/Service
mProbe is aiding oncologists in making informed clinical decisions by providing more comprehensive tumor profiling. And we can deliver more information with less tissue and in less time. With just 2 slides, our patented process allows us to identify over
The content above was translated by Ai
Founded Year
2017
Unified Business No.
52703902
Status
Active
Number of Employees
0
Total Paid-in
Capital
48,500,000 (NT$)
Location of Company
Taiwan
, New Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
mProbe believes that the future is personalized medicine. Only by fully understanding the biology of a patient’s cancer can you determine the optimal treatment for that patient and, more to the point, their unique cancer. When an oncologist has access to proteomic and genomic data from FFPE tissue samples, they receive an additional and invaluable profile of the cancer at the molecular level. This allows the doctor to tailor the treatment directly to the cancer.
The content above was translated by Ai
